Glenmark to strengthen US presence with more generic filings – Business Standard News
0
Mumbai-based pharmaceutical major Glenmark Pharmaceuticals is strengthening its position in the world’s largest drug market, launching more generic copies. The company, which owns a strong drug molecule pipeline, has been filing a large number of ANDAs (abbreviated new drug applications) of Indian companies with the US Food and Drug Administration (FDA) since FY13.
Read more – Business Standard News